Strong association between human and animal brucella seropositivity in a linked study in Kenya, 2012-2013

American Journal of Tropical Medicine and Hygiene

Volumn 93, Issue 2, 2015, Pages 224-231

  Osoro, Eric Mogaka ^a   Munyua, Peninah ^b   Omulo, Sylvia ^b   Ogola, Eric ^b   Ade, Fredrick ^b   Mbatha, Peter ^b   Mbabu, Murithi ^b   Ng'ang'a, Zipporah ^b   Kairu, Salome ^b   Maritim, Marybeth ^b   Thumbi, Samuel M ^b   Bitek, Austine ^b   Gaichugi, Stella ^b   Rubin, Carol ^b   Njenga, Kariuki ^b   Guerra, Marta ^b  

^a MINISTRY OF HEALTH   (Kenya)

^b Centers for Disease Control and Prevention Kenya   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; ANIMAL SEROPREVALENCE; ARTICLE; BOVINE; BRUCELLA ABORTUS; BRUCELLOSIS; CAMEL; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAIRY PRODUCT; FEMALE; GOAT; HOUSEHOLD; HUMAN; HUMAN SEROPREVALENCE; INFECTION CONTROL; KENYA; MALE; MILK; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEROPREVALENCE; SHEEP; STRUCTURED QUESTIONNAIRE; ADOLESCENT; ANIMAL; BLOOD; BRUCELLA; CHILD; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PREVALENCE; SOCIOECONOMICS; STATISTICAL MODEL; TRANSMISSION; VERY ELDERLY; VETERINARY; YOUNG ADULT;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS; BRUCELLA; CAMELIDAE; CAPRA HIRCUS; OVIS ARIES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, BACTERIAL; BRUCELLA; BRUCELLOSIS; CAMELS; CATTLE; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; GOATS; HUMANS; IMMUNOGLOBULIN G; KENYA; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SHEEP; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84939230875     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.15-0113     Document Type: Article

References (44)

1. Corbel MJ, 1997. Brucellosis: an overview. Emerg Infect Dis 3: 213-221.
2. Pappas G, Akritidis N, Bosilkovski M, Tsianos E, 2005. Brucellosis. N Engl J Med 352: 2325-2336.
3. Foster G, Osterman BS, Godfroid J, Jacques I, Cloeckaert A, 2007. Brucella ceti sp. nov. and Brucella pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred hosts. Int J Syst Evol Microbiol 57: 2688-2693.
4. Corbel MJ, 2006. Brucellosis in Humans and Animals. World Health Organization, Food and Agriculture Organization of the United Nations, World Organization for Animal Health, Geneva, Switzerland.
5. Pappas G, Panagopoulou P, Christou L, Akritidis N, 2006. Brucella as a biological weapon. Cell Mol Life Sci 63: 2229-2236.
6. Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS, 2002. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 323: 299-315.
7. Malik GM, 1997. A clinical study of brucellosis in adults in the Asir region of southern Saudi Arabia. Am J Trop Med Hyg 56: 375-377.
8. Henk LSSJC, 2004. Contributions of biotechnology to the control and prevention of brucellosis in Africa. Afr J Biotechnol 12: 631-636.
9. Karadzinska-Bislimovska J, Minov J, Mijakoski D, Stoleski S, Todorov S, 2010. Brucellosis as an occupational disease in the Republic of Macedonia. Macedonian J Med Sci 3: 251-256.
10. Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J, 2012. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis 6: 6
11. Solera J, Martinez-Alfaro E, Espinosa A, 1997. Recognition and optimum treatment of brucellosis. Drugs 53: 245-256.
12. McDermott J, Grace D, Zinsstag J, 2013. Economics of brucellosis impact and control in low-income countries. Rev Sci Tech 32: 249-261.
13. Memish ZA, Balkhy HH, 2004. Brucellosis and international travel. J Travel Med 11: 49-55.
14. World Health Organization, Centers for Disease Control and Prevention and Ministry of Health, 2012. Technical Guidelines for Integrated Disease Surveillance and Response in Kenya. Nairobi, Kenya: Ministry of Health, 350.
15. Maichomo MW, McDermott JJ, Arimi SM, Gathura PB, Mugambi TJ, Muriuki SM, 2000. Study of brucellosis in a pastoral community and evaluation of the usefulness of clinical signs and symptoms in differentiating it from other flu-like diseases. Afr J Health Sci 7: 114-119.
16. Kadohira M, McDermott JJ, Shoukri MM, Kyule MN, 1997. Variations in the prevalence of antibody to Brucella infection in cattle by farm, area and district in Kenya. Epidemiol Infect 118: 35-41.
17. McDermott JJ, Arimi SM, 2002. Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet Microbiol 90: 111-134.
18. Commission on Revenue Allocation, 2011. Kenya County Fact Sheet
19. Kenya National Bureau of Statistics, ICF Macro, 2010. Kenya Demographic and Health Survey 2008-09. Calverton, MD: KNBS and ICF Macro.
20. Quantum GIS Development Team, 2014. Quantum GIS Geographic Information System 2.2.0: Open Source Geospatial Foundation Project.
21. Schaeffer R, Mendenhall W, Ott L, 1990
22. World Health Organization, 2005. Immunization Coverage Cluster Survey: Reference Manual Immunization Vaccines and Biologicals, WHO Vaccine Assessment and Monitoring Team. Geneva, Switzerland: World Health Organization. 115.
23. Ducrotoy MJ, Bertu WJ, Ocholi RA, Gusi AM, Bryssinckx W, Welburn S, Moriyon I, 2014. Brucellosis as an emerging threat in developing economies: lessons from Nigeria. PLoS Negl Trop Dis 8: e3008.
24. Zolzaya B, Selenge T, Narangarav T, Gantsetseg D, Erdenechimeg D, Zinsstag J, Schelling E, 2014. Representative seroprevalences of human and livestock brucellosis in two Mongolian provinces. EcoHealth 11: 356-371.
25. Bonfoh B, Kasymbekov J, Durr S, Toktobaev N, Doherr MG, Schueth T, Zinsstag J, Schelling E, 2012. Representative seroprevalences of brucellosis in humans and livestock in Kyrgyzstan. EcoHealth 9: 132-138.
26. Baba MM, Sarkindared SE, Brisibe F, 2001. Serological evidence of brucellosis among predisposed patients with pyrexia of unknown origin in the northeastern Nigeria. Cent Eur J Public Health 9: 158-161.
27. Kubuafor DK, Awumbila B, Akanmori BD, 2000. Seroprevalence of brucellosis in cattle and humans in the Akwapimsouth district of Ghana: public health implications. Acta Trop 76: 45-48.
28. Dean AS, Bonfoh B, Kulo AE, Boukaya GA, Amidou M, Hattendorf J, Pilo P, Schelling E, 2013. Epidemiology of brucellosis and q Fever in linked human and animal populations in northern Togo. PLoS One 8: e71501.
29. Bernard F, Vincent C, Matthieu L, David R, James D, 2005. Tuberculosis and brucellosis prevalence survey on dairy cattle in Mbarara milk basin (Uganda). Prev Vet Med 67: 267-281.
30. Magona JW, Walubengo J, Galiwango T, Etoori A, 2009. Seroprevalence and potential risk of bovine brucellosis in zerograzing and pastoral dairy systems in Uganda. Trop Anim Health Prod 41: 1765-1771.
31. Jergefa T, Kelay B, Bekana M, Teshale S, Gustafson H, Kindahl H, 2009. Epidemiological study of bovine brucellosis in three agro-ecological areas of central Oromiya, Ethiopia. Rev Sci Tech 28: 933-943.
32. Al-Majali AM, Talafha AQ, Ababneh MM, 2009. Seroprevalence and risk factors for bovine brucellosis in Jordan. J Vet Sci 10: 61-65.
33. El Sherbini A, Kabbash I, Schelling E, El Shennawy S, Shalapy N, Elnaby GH, Helmy AA, Eisa A, 2007. Seroprevalences and local variation of human and livestock brucellosis in two villages in Gharbia Governorate, Egypt. Trans R Soc Trop Med Hyg 101: 923-928.
34. Makita K, Fevre EM, Waiswa C, Eisler MC, Thrusfield M, Welburn SC, 2011. Herd prevalence of bovine brucellosis and analysis of risk factors in cattle in urban and peri-urban areas of the Kampala economic zone, Uganda. BMC Vet Res 7: 1746-6148.
35. Schelling E, Diguimbaye C, Daoud S, Nicolet J, Boerlin P, Tanner M, Zinsstag J, 2003. Brucellosis and Q-fever seroprevalences of nomadic pastoralists and their livestock in Chad. Prev Vet Med 61: 279-293.
36. Muendo EN, Mbatha PM, Macharia J, Abdoel TH, Janszen PV, Pastoor R, Smits HL, 2012. Infection of cattle in Kenya with Brucella abortus biovar 3 and Brucella melitensis biovar 1 genotypes. Trop Anim Health Prod 44: 17-20.
37. Ahmed MO, Elmeshri SE, Abuzweda AR, Blauo M, Abouzeed YM, Ibrahim A, Salem H, Alzwam F, Abid S, Elfahem A, Elrais A, 2010. Seroprevalence of brucellosis in animals and human populations in the western mountains region in Libya, December 2006-January 2008. Euro Surveill 15: 19625.
38. Aworh MK, Okolocha E, Kwaga J, Fasina F, Lazarus D, Suleman I, Poggensee G, Nguku P, Nsubuga P, 2013. Human brucellosis: seroprevalence and associated exposure factors among abattoir workers in Abuja, Nigeria-2011. Pan Afr Med J 16: 103.
39. Mukhtar F, 2010. Brucellosis in a high risk occupational group: seroprevalence and analysis of risk factors. J Pak Med Assoc 60: 1031-1034.
40. John K, Fitzpatrick J, French N, Kazwala R, Kambarage D, Mfinanga GS, MacMillan A, Cleaveland S, 2010. Quantifying risk factors for human brucellosis in rural northern Tanzania. PLoS One 5: e9968.
41. Kozukeev TB, Ajeilat S, Maes E, Favorov M, 2006. Risk factors for brucellosis-Leylek and Kadamjay districts, Batken Oblast, Kyrgyzstan, January-November, 2003. MMWR Morb Mortal Wkly Rep 1: 31-34.
42. Irmak H, Buzgan T, Evirgen O, Akdeniz H, Demiroz AP, Abdoel TH, Smits HL, 2004. Use of the Brucella IgM and IgG flow assays in the serodiagnosis of human brucellosis in an area endemic for brucellosis. Am J Trop Med Hyg 70: 688-694.
43. Serra J, Vinas M, 2004. Laboratory diagnosis of brucellosis in a rural endemic area in northeastern Spain. Int Microbiol 7: 53-58.
44. Kasymbekov J, Imanseitov J, Ballif M, Schurch N, Paniga S, Pilo P, Tonolla M, Benagli C, Akylbekova K, Jumakanova Z, Schelling E, Zinsstag J, 2013. Molecular epidemiology and antibiotic susceptibility of livestock Brucella melitensis isolates from Naryn Oblast, Kyrgyzstan. PLoS Negl Trop Dis 7: e2047.